Chinese University of Hong Kong: Diabetes Mellitus trials

The registry lists 36 Diabetes Mellitus studies with Chinese University of Hong Kong as lead sponsor. 8 are open to participants now and 2 have results posted.

Phase 2 4Phase 3 1Phase 4 4No phase 27(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Duodenal pulsENDO as an Early Treatment for Type 2 DMRecruitingNCT07376486Not applicable
• Hong Kong Gestational Diabetes Register (HKGDR)Enrolling by invitationNCT07271407
• Novel Chinese Medicine Formula for DiabetesNot yet recruitingNCT06978023Phase 2
• Glucokinase Activator in Monogenic DiabetesRecruitingNCT06976658Phase 2
• Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney DiseaseRecruitingNCT06727409Phase 4
• The Extension of HAPO Follow-up StudyRecruitingNCT05477511
• Archival of Human Biological Samples in CU-Med BiobankRecruitingNCT04706481
• Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style InterventionRecruitingNCT03875625Not applicable
• Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder MessagesCompletedNCT04241575Not applicableResults posted
• BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in Subjects With Pre-DiabetesCompletedNCT02358668Phase 2Results posted
• ACT-DE for Diabetes Distress in Adults With Type 2 Diabetes: A Pilot RCTCompletedNCT05563987Not applicable
• Chinese Smartphone App for 6-18 Years With T1DM - RCTStatus unknownNCT05418569Not applicable
• The Hong Kong Diabetes BiobankActive, not recruitingNCT05282680
• Prediction to Detect Pre-DM/DM in a Chinese PopulationCompletedNCT05116319
• Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic DiabetesCompletedNCT04531631Phase 2
• Diabetes Care Programme for Type 2 Diabetes Mellitus in Primary Care SettingStatus unknownNCT04348565Not applicable
• Effectiveness of Pre-medical Consultation Diabetes Self-care Education Programme on Glycemic Control in Type 2 DiabetesStatus unknownNCT04092569Not applicable
• Precision Medicine in Chinese Patients With Young Onset DiabetesStatus unknownNCT04049149Not applicable
• The Influence of HDL Function on Cognitive FunctionCompletedNCT03761719
• Lifestyle Modification to Improve Diet in Women With GDMCompletedNCT03669887Not applicable
• MBCT for DM Distress: a Pilot Qusai-experimental StudyCompletedNCT03484689Not applicable
• Effectiveness of a Nurse-led Integrative Health and Wellness Programme Among Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT03261895Not applicable
• BEYO Project to Promote Sense of Coherence and Self-care of Elderly People With Type 2 DiabetesStatus unknownNCT03237975Not applicable
• Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DMCompletedNCT03127696Not applicable
• Single Loop DJB Sleeve Gastrectomy for Poorly Controlled T2DMStatus unknownNCT03125369Not applicable
• Multi-centre Peer Support Program in Type 2 Diabetes Patients in Hong KongStatus unknownNCT02486172Not applicable
• Lifestyle Intervention and Prevention of Gestational Diabetes MellitusCompletedNCT02368600Not applicable
• Effect of Personalized Feedback Report and Peer Support on DiabetesCompletedNCT02199834Not applicable
• Prevalence Study of Depression in Chinese Patients With Type 2 Diabetes (HK13)CompletedNCT01277432
• JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic PatientsCompletedNCT01269996Phase 4
• Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control TrialStatus unknownNCT00975533Phase 3
• PEARL Program: Empowerment Program for Patients With Type 2 Diabetes (HK4)CompletedNCT00950716Not applicable
• Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and DiabetesTerminatedNCT00816010Not applicable
• Community Health Worker Reduces Care UtilizationCompletedNCT00711152Phase 4
• Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With NephropathyCompletedNCT00309127Not applicable
• The Use of Cilostazol in Patients With Diabetic NephropathyCompletedNCT00272831Phase 4